Tevogen Bio (TVGN) News Today → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free TVGN Stock Alerts $1.00 +0.15 (+17.65%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTevogen Bio Inc: Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointmentsfinanznachrichten.de - April 27 at 2:20 AMTevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointmentsglobenewswire.com - April 26 at 9:23 AMU.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.98%msn.com - April 26 at 2:04 AMTevogen Bio (NASDAQ:TVGN) Stock Price Down 1.2%americanbankingnews.com - April 24 at 3:02 AMTevogen Bio Holdings Inc TVGNmorningstar.com - April 20 at 5:36 PMLive Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Sessionmsn.com - April 16 at 8:17 AMTevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancersfinance.yahoo.com - April 11 at 12:52 PMTevogen Bio's Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancersglobenewswire.com - April 11 at 8:05 AMTVGN Tevogen Bio Holdings Inc.seekingalpha.com - April 5 at 11:11 PMWhy Is Tevogen Bio (TVGN) Stock Up 46% Today?investorplace.com - April 4 at 10:12 AMTevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Developmentglobenewswire.com - April 3 at 8:05 AMTevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Priceglobenewswire.com - March 28 at 8:05 AMTevogen Bio Announces Series A-1 Preferred Stock Investmentglobenewswire.com - March 27 at 9:20 AMTevogen Bio Reports Its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 Variantbusinesswire.com - March 20 at 7:00 AMMittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AIbusinesswire.com - February 27 at 4:39 PMCell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatmentbusinesswire.com - February 21 at 7:00 AMmarketbeat.com - February 20 at 9:36 AMCell Therapy Company Tevogen Bio Holdings Inc. (Nasdaq: TVGN) Rings Opening Bell at Nasdaq Exchange on February 15th, 2024, Begins Public Trading on the Open Marketbusinesswire.com - February 17 at 12:17 AMmarketbeat.com - February 16 at 3:55 PMmarketbeat.com - February 16 at 2:21 PMmarketbeat.com - February 16 at 9:52 AMmarketbeat.com - February 16 at 9:43 AMmarketbeat.com - February 16 at 9:34 AMmarketbeat.com - February 15 at 2:29 PMmarketbeat.com - February 15 at 2:08 PMmarketbeat.com - February 15 at 12:55 PMmarketbeat.com - February 15 at 12:39 PMmarketbeat.com - February 15 at 12:30 PMmarketbeat.com - February 15 at 12:18 PMmarketbeat.com - February 15 at 11:59 AMmarketbeat.com - February 15 at 11:38 AMmarketbeat.com - February 15 at 11:33 AMmarketbeat.com - February 15 at 11:26 AMmarketbeat.com - February 15 at 11:17 AMmarketbeat.com - February 15 at 11:07 AMmarketbeat.com - February 15 at 10:28 AMmarketbeat.com - February 15 at 10:24 AMmarketbeat.com - February 15 at 9:57 AMTevogen Bio Announces $8 Million Equity Investmentbusinesswire.com - February 15 at 9:25 AMTevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGNglobenewswire.com - February 14 at 3:55 PM Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. TVGN Media Mentions By Week TVGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TVGN News Sentiment▼-0.200.32▲Average Medical News Sentiment TVGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TVGN Articles This Week▼54▲TVGN Articles Average Week Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Protara Therapeutics News Today MiNK Therapeutics News Today Achilles Therapeutics News Today Pluri News Today IN8bio News Today NKGen Biotech News Today Cyclo Therapeutics News Today AIM ImmunoTech News Today Evaxion Biotech A/S News Today ZIVO Bioscience News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TVGN) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tevogen Bio Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
